More about
Advanced Large B-Cell Lymphoma
News
February 20, 2023
3 min read
Save
New treatment target emerges for those who relapse after CAR-T for lymphoma
A novel chimeric antigen receptor T-cell therapy induced response among adults with advanced large B-cell lymphoma who relapsed after previous CAR-T, study results showed.
News
November 28, 2022
1 min read
Save
FDA grants priority review to epcoritamab for advanced lymphoma
The FDA granted priority review to epcoritamab for treatment of certain patients with advanced lymphoma, according to the agent’s manufacturer.